|
"lu yen shen"的相關文件
顯示項目 36-85 / 109 (共3頁)
1 2 3 > >>
每頁顯示[10|25|50]項目
| 國立臺灣大學 |
2016 |
Clinical Relevance of Liver Kinase B1(LKB1) Protein and Gene Expression in Breast Cancer
|
Chen, I-Chun; Chang, Yuan-Ching; Lu, Yen-Shen; Chung, Kuei-Pin; Huang, Chiun-Sheng; Lu, Tzu-Pin; Kuo, Wen-Hung; Wang, Ming-Yang; Kuo, Kuan-Ting; Wu, Pei-Fang; Hsueh, Tsu-Hsin; Shen, Chen-Yang; Lin, Ching-Hung; Cheng, Ann-Lii; 林志弘; 郭文宏; 盧彥伸; 林璟宏; 盧子彬; 陳怡君; 郭冠廷; 吳佩芳; 鄭安理; 黃俊升; 王明暘; 鐘桂彬; 林季宏 |
| 國立臺灣大學 |
2016 |
Locoregional Recurrence Risk for Postmastectomy Breast Cancer Patients With T1-2 and One to Three Positive Lymph Nodes Receiving Modern Systemic Treatment Without Radiotherapy
|
Lai, Shih-Fan; Chen, Yu-Hsuan; Kuo, Wen-Hung; Lien, Huang-Chun; Wang, Ming-Yang; Lu, Yen-Shen; Lo, Chiao; Kuo, Sung-Hsin; Cheng, Ann-Lii; Huang, Chiun-Sheng; 郭文宏; 盧彥伸; 連晃駿; 郭頌鑫; 鄭安理; 陳育瑄; 黃俊升; 王明暘 |
| 國立臺灣大學 |
2016 |
A pilot study to determine the timing and effect of bevacizumab on vascular normalization of metastatic brain tumors in breast cancer
|
Chen, Bang-Bin; Lu, Yen-Shen; Lin, Ching-Hung; Chen, Wei-Wu; Wu, Pei-Fang; Hsu, Chao-Yu; Yu, Chih-Wei; Wei, Shwu-Yuan; Cheng, Ann-Lii; Shih, Tiffany Ting-Fang; 陳偉武; 盧彥伸; 林璟宏; 施庭芳; 許昭禹; 吳佩芳; 鄭安理; 陳邦斌; 魏淑圓; 游治維; 林季宏 |
| 國立臺灣大學 |
2016 |
Tailor the adjuvant hormonal manipulation for premenopausal breast cancer patients
|
Chen, Tom Wei-Wu; Lin, Ching-Hung; Lu, Yen-Shen; 林志弘; 陳偉武; 盧彥伸; 林璟宏; 林季宏 |
| 國立臺灣大學 |
2016 |
Bevacizumab might potentiate the chemotherapeutic effect in breast cancer patients with leptomeningeal carcinomatosis
|
Chen, I-Chun; Lin, Ching-Hung; Jan, I-Shiow; Cheng, Ann-Lii; Lu, Yen-Shen; 盧彥伸; 林璟宏; 詹一秀; 陳怡君; 鄭安理; 林季宏 |
| 國立臺灣大學 |
2016 |
Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer
|
Lin, Po-Han; Kuo, Wen-Hung; Huang, Ai-Chu; Lu, Yen-Shen; Lin, Ching-Hung; Kuo, Sung-Hsin; Wang, Ming-Yang; Liu, Chun-Yu; Cheng, Fiona Tsui-Fen; Yeh, Ming-Hsin; Li, Huei-Ying; Yang, Yu-Hsuan; Hsu, Yu-Hua; Fan, Sheng-Chih; Li, Long-Yuan; Yu, Sung-Liang; Chang, King-Jen; Chen, Pei-Lung; Ni, Yen-Hsuan; Huang, Chiun-Sheng; 郭文宏; 盧彥伸; 林璟宏; 倪衍玄; 郭頌鑫; 黃愛珠; 黃俊升; 林柏翰; 陳沛隆; 王明暘; 林季宏 |
| 國立臺灣大學 |
2015 |
High Prevalence of the BIM Deletion Polymorphism in Young Female Breast Cancer in an East Asian Country
|
Lin, Ching-Hung; Shen, Chen-Yang; Lee, Jih-Hsiang; Huang, Chiun-Sheng; Yang, Chih-Hsin; Kuo, Wen-Hung; Chang, Dwan-Ying; Hsiung, Chia-Ni; Kuo, Kuan-Ting; Chen, Wei-Wu; Chen, I-Chun; Wu, Pei-Fang; Kuo, Sung-Hsin; Chen, Chien-Jen; Lu, Yen-Shen; Cheng, Ann-Lii; 林志弘; 楊志新; 陳偉武; 郭文宏; 盧彥伸; 林璟宏; 陳怡君; 郭冠廷; 郭頌鑫; 吳佩芳; 鄭安理; 黃俊升; 張端瑩; 李日翔; 林季宏 |
| 國立臺灣大學 |
2015 |
Randomized study of tailored neoadjuvant chemotherapy according to the expression of tau, topo II alpha, and ERCC1 versus standard chemotherapy in HER2-negative breast cancer
|
Lu, Yen-Shen; Yeh, Dah-Cherng; Tseng, Ling-Ming; Chen, Shou-Tung; Lien, Huang-Chun; Chang, Hong-Tai; Chang, Yuan-Ching; Huang, Shu-Min; Lin, Ching-Hung; Cheng, Ann-Lii; Huang, Chiun-Sheng; 盧彥伸; 林璟宏; 連晃駿; 鄭安理; 黃俊升 |
| 國立臺灣大學 |
2015 |
Clinical significance of LKB1 protein and gene expression in breast cancer.
|
Chen, I. Chun; Chang, Yuan-Ching; Lu, Yen-Shen; Huang, Chiun-Sheng; Kuo, Wen-Hung; Wang, Ming-Yang; Kuo, Kuan-Ting; Wu, Pei-Fang; Hsueh, Tsu-Hsin; Lin, Ching-Hung; Cheng, Ann-Lii; 盧彥伸; 林璟宏; 郭冠廷; 吳佩芳; 鄭安理; 黃俊升; 王明暘 |
| 國立臺灣大學 |
2015 |
TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays
|
Lin, Ching-Hung; Chen, I-Chiun; Huang, Chiun-Sheng; Hu, Fu-Chang; Kuo, Wen-Hung; Kuo, Kuan-Ting; Wang, Chung-Chieh; Wu, Pei-Fang; Chang, Dwan-Ying; Wang, Ming-Yang; Chang, Chin-Hao; Chen, Wei-Wu; Lu, Yen-Shen; Cheng, Ann-Lii; 林志弘; 陳偉武; 郭文宏; 盧彥伸; 林璟宏; 陳怡君; 郭冠廷; 王中傑; 吳佩芳; 鄭安理; 黃俊升; 張端瑩; 王明暘; 張晉豪; 林季宏 |
| 國立臺灣大學 |
2015 |
BKM120 and BYL719 (PI3K inhibitors) sensitize estrogen receptor positive breast cancer cells to tamoxifen
|
Chen, I-Chun; Gao, Ming; Hsiao, Lii-Ping; Huang, Yi-Wen; Yu, Huei-Chieh; Yeh, Ling-Chiun; Cheng, Ann-Lii; Lu, Yen-Shen; 盧彥伸; 陳怡君; 鄭安理 |
| 國立臺灣大學 |
2015 |
A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis
|
Wu, Pei-Fang; Lin, Ching-Hung; Kuo, Ching-Hua; Chen, Wei-Wu; Yeh, Dah-Cherng; Liao, Hsiao-Wei; Huang, Shu-Min; Cheng, Ann-Lii; Lu, Yen-Shen; 陳偉武; 盧彥伸; 林璟宏; 郭錦樺; 吳佩芳; 鄭安理; 林季宏 |
| 國立臺灣大學 |
2015 |
Bevacizumab Preconditioning Followed by Etoposide and Cisplatin Is Highly Effective in Treating Brain Metastases of Breast Cancer Progressing from Whole-Brain Radiotherapy
|
Lu, Yen-Shen; Chen, Tom Wei-Wu; Lin, Ching-Hung; Yeh, Dah-Cherng; Tseng, Ling-Ming; Wu, Pei-Fang; Rau, Kun-Ming; Chen, Bang-Bin; Chao, Ta-Chung; Huang, Shu-Min; Huang, Chiun-Sheng; Shih, Tiffany Ting-Fang; Cheng, Ann-Lii; 林志弘; 陳偉武; 盧彥伸; 林璟宏; 施庭芳; 吳佩芳; 鄭安理; 陳邦斌; 黃俊升; 林季宏 |
| 國立臺灣大學 |
2015 |
Evaluation of the treatment response to neoadjuvant chemotherapy in locally advanced breast cancer using combined magnetic resonance vascular maps and apparent diffusion coefficient
|
Wu, Li-An; Chang, Ruey-Feng; Huang, Chiun-Sheng; Lu, Yen-Shen; Chen, Hong-Hao; Chen, Jo-Yu; Chang, Yeun-Chung; 盧彥伸; 張允中; 陳若瑀; 黃俊升 |
| 國立臺灣大學 |
2014 |
Differential expression of hyaluronan synthase 2 in breast carcinoma and its biological significance
|
Lien, Huang-Chun; Lee, Yi-Hsuan; Jeng, Yung-Ming; Lin, Ching-Hung; Lu, Yen-Shen; Yao, Yu-Tung; 盧彥伸; 鄭永銘; 林璟宏; 連晃駿; 李宜軒; 林季宏; 饒宇東 |
| 國立臺灣大學 |
2014 |
No increased venous thromboembolism risk in Asian breast cancer patients receiving adjuvant tamoxifen
|
Chen, Tom Wei-Wu; Chen, Ho-Min; Lin, Ching-Hung; Huang, Chiun-Sheng; Cheng, Ann-Lii; Lai, Mei-Shu; Lu, Yen-Shen; 陳偉武; 盧彥伸; 林璟宏; 賴美淑; 鄭安理; 黃俊升; 林季宏 |
| 國立臺灣大學 |
2014 |
Quantification of target analytes in various biofluids using a postcolumn infused-internal standard method combined with matrix normalization factors in liquid chromatography-electrospray ionization mass spectrometry
|
Liao, Hsiao-Wei; Tsai, I-Lin; Chen, Guan-Yuan; Lu, Yen-Shen; Lin, Ching-Hung; Kuo, Ching-Hua; 盧彥伸; 林璟宏; 郭錦樺; 林季宏 |
| 國立臺灣大學 |
2014 |
Distinct Clinicopathological Features and Prognosis of Emerging Young-Female Breast Cancer in an East Asian Country: A Nationwide Cancer Registry-Based Study
|
Lin, Ching-Hung; Chuang, Po-Ya; Chiang, Chun-Ju; Lu, Yen-Shen; Cheng, Ann-Lii; Kuo, Wen-Hung; Huang, Chiun-Sheng; Lai, Mei-Shu; You, San-Lin; Tang, Chao-Hsiun; 林志弘; 郭文宏; 盧彥伸; 林璟宏; 賴美淑; 鄭安理; 黃俊升; 林季宏 |
| 國立臺灣大學 |
2013 |
Clinical significance of ESR1 gene copy number changes in breast cancer as measured by fluorescence in situ hybridisation
|
Lin, Ching-Hung; Liu, Jacqueline M.; Lu, Yen-Shen; Lan, Chieh; Lee, Wei-Chung; Kuo, Kuan-Ting; Wang, Chung-Chieh; Chang, Dwan-Ying; Huang, Chiun-Sheng; Cheng, Ann-Lii; 盧彥伸; 郭冠廷; 王中傑; 鄭安理; 黃俊升; 張端瑩; 林璟宏 |
| 國立臺灣大學 |
2013 |
The first two lines of chemotherapy for anthracycline-naive metastatic breast cancer: A comparative study of the efficacy of anthracyclines and non-anthracyclines
|
Chen, Wei-Wu; Chang, Dwan-Ying; Huang, Shu-Min; Lin, Ching-Hung; Hsu, Chun; Lin, Ming-Hwai; Huang, Chiun-Shen; Lu, Yen-Shen; Cheng, Ann-Lii; 陳偉武; 盧彥伸; 鄭安理; 許駿; 黃俊升; 張端瑩; 林璟宏 |
| 國立臺灣大學 |
2013 |
Phosphorylated insulin-like growth factor-1 receptor (pIGF1R) is a poor prognostic factor in brain metastases from lung adenocarcinomas
|
Wu, Pei-Fang; Huang, Wen-Chang; Yang, James Chih-Hsin; Lu, Yen-Shen; Shih, Jin-Yuan; Wu, Shang-Gin; Lin, Ching-Hung; Cheng, Ann-Lii; 楊志新; 盧彥伸; 鄭安理; 吳尚俊; 施金元; 林璟宏 |
| 國立臺灣大學 |
2013 |
Differential expression of ubiquitin carboxy-terminal hydrolase L1 in breast carcinoma and its biological significance
|
Lien, Huang-Chun; Wang, Chung-Chieh; Lin, Ching-Hung; Lu, Yen-Shen; Huang, Chiun-Sheng; Hsiao, Li-Ping; Yao, Yu-Tung; 連晃駿; 黃俊升; 饒宇東 |
| 國立臺灣大學 |
2012 |
The emerging epidemic of estrogen-related cancers in young women in a developing Asian country
|
Lin, Ching-Hung; Chen, Yong-Chen; Chiang, Chun-Ju; Lu, Yen-Shen; Kuo, Kuan-Ting; Huang, Chiun-Sheng; Cheng, Wen-Fang; Lai, Mei-Shu; You, San-Lin; Cheng, Ann-Lii; 鄭文芳; 盧彥伸; 賴美淑; 郭冠廷; 鄭安理; 黃俊升; 林璟宏 |
| 國立臺灣大學 |
2012 |
Efficacy, Safety, and Potential Biomarkers of Thalidomide plus Metronomic Chemotherapy for Advanced Hepatocellular Carcinoma
|
Shao, Yu-Yun; Lin, Zhong-Zhe; Hsu, Chiun; Lee, Kuan-Der; Hsiao, Chi-Huang; Lu, Yen-Shen; Huang, Chien-Chung; Shen, Yin-Chun; Hsu, Chih-Hung; Cheng, Ann-Lii; 盧彥伸; 邵幼雲; 林宗哲; 鄭安理; 徐志宏; 許駿 |
| 國立臺灣大學 |
2012 |
The Impact of Diabetes Mellitus on Prognosis of Early Breast Cancer in Asia
|
Chen, Wei-Wu; Shao, Yu-Yun; Shau, Wen-Yi; Lin, Zhong-Zhe; Lu, Yen-Shen; Chen, Ho-Min; Kuo, Raymond N. C.; Cheng, Ann-Lii; Lai, Mei-Shu; 陳偉武; 盧彥伸; 邵幼雲; 賴美淑; 林宗哲; 鄭安理 |
| 國立臺灣大學 |
2012 |
Dynamics of circulating endothelial cells and endothelial progenitor cells in breast cancer patients receiving cytotoxic chemotherapy
|
Kuo, Yu-Hsuan; Lin, Ching-Hung; Shau, Wen-Yi; Chen, Te-Jung; Yang, Shih-Hung; Huang, Shu-Min; Hsu, Chun; Lu, Yen-Shen; Cheng, Ann-Lii; 盧彥伸; 鄭安理; 許駿; 楊士弘; 林璟宏 |
| 國立臺灣大學 |
2012 |
Multimodel assessment of BRCA1 mutations in Taiwanese (ethnic Chinese) women with early-onset, bilateral or familial breast cancer
|
Kuo, Wen-Hong; Lin, Po-Han; Huang, Ai-Chu; Chien, Yin-Hsiu; Liu, Tsang-Pai; Lu, Yen-Shen; Bai, Li-Yuan; Sargeant, Aaron M.; Lin, Ching-Hung; Cheng, Ann-Lii; Hsieh, Fon-Jou; Hwu, Wuh-Liang; Chang, King-Jen; 胡務亮; 郭文宏; 盧彥伸; 張金堅; 謝豐舟; 鄭安理; 黃愛珠; 簡穎秀; 林柏翰; 林璟宏 |
| 國立臺灣大學 |
2012 |
Radiosensitizing Effect of a Phenylbutyrate-Derived Histone Deacetylase Inhibitor in Hepatocellular Carcinoma
|
Lu, Yen-Shen; Chou, Chia-Hung; Tzen, Kai-Yuan; Gao, Ming; Cheng, Ann-Lii; Kulp, Samuel K.; Cheng, Jason Chia-Hsien; 盧彥伸; 曾凱元; 鄭安理; 成佳憲 |
| 國立臺灣大學 |
2012 |
Differential expression of moesin in breast cancers and its implication in epithelial-mesenchymal transition
|
Wang, Chung-Chieh; Liau, Jau-Yu; Lu, Yen-Shen; Chen, Jun-Wei; Yao, Yu-Tung; Lien, Huang-Chun; 連晃駿; 王中傑; 廖肇裕; 饒宇東 |
| 國立臺灣大學 |
2010-12 |
O(6)-Methylguanine-DNA methyltransferase expression and prognostic value in brain metastases of lung cancers
|
Wu, Pei-Fang; Kuo, Kuan-Ting; Kuo, Lu-Ting; Lin, Yi-Ting; Lee, Wei-Chung; Lu, Yen-Shen; Yang, Chih-Hsin; Wu, Ruey-Meei; Tu, Yong-Kwang; Tasi, Jui-Chang; Tseng, Ham-Min; Tseng, Sheng-Hong; Cheng, Ann-Lii; Lin, Ching-Hung |
| 國立臺灣大學 |
2010 |
O-6-Methylguanine-DNA Methyltransferase Expression and Prognostic Value in Brain Metastases of Lung Cancers
|
吳佩芳; 郭冠廷; 郭律廷; 林怡婷; 盧彥伸; 楊志新; 吳瑞美; 杜永光; 蔡瑞章; 曾漢民; 曾勝弘; 鄭安理; 林璟宏; WU, PEI-FANG; KUO, KUAN-TING; KUO, LU-TING; LIN, YI-TING; LU, YEN-SHEN; YANG, CHIH-HSIN; WU, RUEY-MEEI; TU, YONG-KWANG; TSAI, JUI-CHANG; TSENG, HAN-MIN; TSENG, SHENG-HONG; CHENG, ANN-LII; LIN, CHING-HUNG |
| 國立臺灣大學 |
2010 |
Combinations of Mtorc1 Inhibitor Rad001 with Gemcitabine and Paclitaxel for Treating Non-Hodgkin Lymphoma
|
江俊德; 葉培彥; 高明; 郭頌鑫; 徐志宏; 盧彥伸; 鄭安理; CHIANG, CHUN-TE; YEH, PEI-YEN; GAO, MING; KUO, SUNG-HSIN; HSU, CHIH-HUNG; LU, YEN-SHEN; CHENG, ANN-LII |
| 國立臺灣大學 |
2010 |
Fractionated Evaluation of Immunohistochemical Hormone Receptor Expression Enhances Prognostic Prediction in Breast Cancer Patients Treated with Tamoxifen as Adjuvant Therapy
|
林璟宏; 連晃駿; 胡賦强; 盧彥伸; 郭頌鑫; 游山林; 鄭安理; 黃俊升; LIN, CHING-HUNG; LIEN, HUANG-CHUN; HU, FU-CHANG; LU, YEN-SHEN; KUO, SUNG-HSIN; YOU, SAN-LIN; CHENG, ANN-LII; HUANG, CHIUN-SHENG |
| 國立臺灣大學 |
2010 |
Management of Erbb2-Positive Breast Cancer: Insights from Preclinical and Clinical Studies with Lapatinib
|
盧彥伸; LU, YEN-SHEN |
| 國立臺灣大學 |
2010 |
Predictive and Prognostic Values of Tau and Ercc1 in Advanced Breast Cancer Patients Treated with Paclitaxel and Cisplatin
|
邵幼雲; 郭冠廷; 胡賦强; 盧彥伸; 黃俊升; 廖肇裕; 許駿; 郭文宏; 張金堅; 林璟宏; 鄭安理; SHAO, YU-YUN; KUO, KUAN-TING; HU, FU-CHANG; LU, YEN-SHEN; HUANG, CHIUN-SHENG; LIAU, JAO-YU; HSU, CHIUN; KUO, WEN-HONG; CHANG, KING-JEN; LIN, CHING -HUNG; CHENG, ANN-LII |
| 國立臺灣大學 |
2010 |
The Prevalence and Assessment of Erbb2-Positive Breast Cancer in Asia: A Literature Survey
|
盧彥伸; LU, YEN-SHEN |
| 國立臺灣大學 |
2010 |
Vinorelbine Plus 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin as Effective Palliative Chemotherapy for Breast Cancer Patients with Acute Disseminated Intravascular Coagulation
|
林柏翰; 盧彥伸; 林璟宏; 黃俊升; 鄭安理; 葉坤輝; LIN, PO-HAN; LU, YEN-SHEN; LIN, CHING-HUNG; HUANG, CHIUN-SHENG; CHENG, ANN-LII; YEH, KUN-HUEI |
| 國立臺灣大學 |
2009 |
Induction of Bim Expression Contributes to the Antitumor Synergy between Sorafenib and Mitogen-Activated Protein Kinase/Extracellular Signal- Regulated Kinase Kinase Inhibitor Ci-1040 in Hepatocellular Carcinoma
|
歐大諒; 沈盈君; 梁嘉德; 劉俊揚; 俞松良; 盧彥伸; 許駿; 鄭安理; OU, DA-LIANG; SHEN, YING-CHUN; LIANG, JA-DER; LIOU, JUN-YANG; YU, SUNG-LIANG; LU, YEN-SHEN; HSU, CHIUN; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Management of Her2-Positive Breast Cancer in Asia:Consensus Statement from the Asian Oncology Summit 2
|
盧彥伸; LU, YEN-SHEN |
| 國立臺灣大學 |
2009 |
Molecular Subtypes of Breast Cancer Emerging in Young Women in Taiwan: Evidence for More Than Just Westernization as a Reason for the Disease in Asia
|
林璟宏; 盧彥伸; 黃俊升; 沈盈君; 郭頌鑫; 劉敏; 張金堅; 鄭安理; LIN, CHING-HUNG; LU, YEN-SHEN; HUANG, CHIUN-SHENG; SHEN, YING-CHUN; KUO, SUNG-HSIN; LIU, JACQUELINE MING; CHANG, KING-JEN; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Poor Response to Systemic Chemotherapy in Metaplastic Carcinoma of Breast
|
盧彥伸; 黃俊升; 鄭安理; LU, YEN-SHEN; HUANG, CHIUN-SHENG; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Resource-Based Data Availability for Erbb2-Driven Breast Cancer in Asian Women: Experts' Opinion
|
盧彥伸; LU, YEN-SHEN |
| 國立臺灣大學 |
2009 |
Locoregional Therapy Improves Survival for Metastatic Breast Cancer Patients? Benefit Remains Questionable!
|
張端瑩; 林璟宏; 盧彥伸; CHANG, DWAN-YING; LIN, CHING-HUNG; LU, YEN-SHEN |
| 國立臺灣大學 |
2009 |
Bortezomib Overcomes Trail Resistance in Hepatocellular Carcinoma Cells in Part through the Inhibition of P13k/Akt Pathway
|
陳昆鋒; 葉培彥; 許駿; 徐志宏; 盧彥伸; 謝興邦; 陳培哲; 鄭安理; CHEN, KUEN-FENG; YEH, PEI-YEN; HSU, CHIUN; HSU, CHIH-HUNG; LU, YEN-SHEN; HSIEH, HSING-PANG; CHEN, PEI-JER; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Bortezomib Overcomes Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Resistance in Hepatocellular Carcinoma Cells in Part through the Inhibition of the Phosphatidylinositol 3-Kinase/Akt Pathway
|
陳昆鋒; 葉培彥; 許駿; 徐志宏; 盧彥伸; 謝興邦; 陳培哲; 鄭安理; CHEN, KUEN-FENG; YEH, PEI-YEN; HSU, CHIUN; HSU, CHIH-HUNG; LU, YEN-SHEN; HSIEH, HSING-PANG; CHEN, PEI-JER; CHENG, ANN-LII |
| 國立臺灣大學 |
2008 |
The Cyp19 Ttta Repeat Polymorphism Is Related to the Prognosis of Premenopausal Stage I-Ii and Operable Stage Iii Breast Cancers
|
黃俊升; 郭頌鑫; 連晃駿; 楊士儀; 游山林; 沈志陽; 林璟宏; 盧彥伸; 張金堅; HUANG, CHIUN-SHENG; KUO, SUNG-HSIN; LIEN, HUANG-CHUN; YANG, SHI-YI; YOU, SAN-LIN; SHEN, CHEN-YANG; LIN, CHING-HUNG; LU, YEN-SHEN; CHANG, KING-JEN |
| 國立臺灣大學 |
2008 |
Lesson of the Month - Differential Expression of Glucocorticoid Receptor in Carcinomas of the Human Digestive System
|
連晃駿; 盧彥伸; 孫家棟; 饒宇東; 張文靜; 鄭安理; LIEN, HUANG-CHUN; LU, YEN-SHEN; SHUN, CHIA-TUNG; YAO, YU-TUNG; CHANG, WEN-CHING; CHENG, ANN-LII |
| 國立臺灣大學 |
2008 |
Dose Variation and Regimen Modification of Adjuvant Chemotherapy in Daily Practice Affect Survival of Stage I-Ii and Operable Stage Iii Taiwanese Breast Cancer Patients
|
郭頌鑫; 連晃駿; 游山林; 盧彥伸; 林璟宏; 黃俊升; KUO, SUNG-HSIN; LIEN, HUANG-CHUN; YOU, SAN-LIN; LU, YEN-SHEN; LIN, CHING-HUNG; HUANG, CHIUN-SHENG |
| 國立臺灣大學 |
2008 |
Fty720 Induces Apoptosis in Hepatocellular Carcinoma Cells through Activation of Protein Kinase C Delta Signaling
|
洪瑞祥; 盧彥伸; 鄭安理; 陳慶士; HUNG, JUI-HSIANG; LU, YEN-SHEN; CHENG, ANN-LII; CHEN, CHING-SHIH |
| 國立臺灣大學 |
2008 |
Nf-Kappa B P50 Promotes Tumor Cell Invasion through Negative Regulation of Invasion Suppressor Gene Crmp-1 in Human Lung Adenocarcinoma Cells
|
高明; 葉培彥; 盧彥伸; 張文靜; 郭明良; 鄭安理; GAO, MING; YEH, PEI-YEN; LU, YEN-SHEN; CHANG, WEN-CHING; KUO, MIN-LIANG; CHENG, ANN-LII |
顯示項目 36-85 / 109 (共3頁)
1 2 3 > >>
每頁顯示[10|25|50]項目
|
